HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis by Jacques, DA et al.
HIV-1 capsids possess dynamic pores that import nucleotides with kinetic 1	
perfection 2	
 3	
During the early stages of infection, the HIV-1 capsid protects viral components from cytosolic 4	
sensors, such as cGAS, and nucleases, such as TREX, while allowing access to nucleotides for 5	
efficient reverse transcription1. Here we show that each capsid hexamer has a size-selective pore 6	
bounded by a ring of six arginine residues and a ‘molecular iris’ formed by the N-terminal β-7	
hairpin. The arginine ring creates a strongly positively charged channel that recruits the four 8	
nucleotides with on-rates that near diffusion limits. Progressive removal of pore arginines results 9	
in a dose-dependent and concomitant decrease in nucleotide affinity, reverse transcription and 10	
infectivity. This positively charged channel is universally conserved in lentiviral capsids despite 11	
the fact that it is strongly destabilising without nucleotides to counteract charge repulsion. We 12	
also describe a channel inhibitor, hexacarboxybenzene, which competes for nucleotide binding 13	
and efficiently blocks encapsidated reverse transcription demonstrating the tractability of the 14	
pore as a novel drug target.  15	
 16	
There is increasing evidence that the HIV-1 capsid remains intact as it traverses the cytoplasm of a 17	
newly-infected cell.  Prematurely-uncoated viruses trigger innate immune sensing2, assembled capsid 18	
proteins are required to properly engage the nuclear pore complex3, and intact capsids have been 19	
observed at the nuclear envelope4.  Reverse transcription has been postulated to occur within the HIV-1 20	
virion during cytoplasmic transit, yet structural analyses of the HIV-1 capsid have not defined a pore 21	
through which small molecules such as dNTP’s might pass. One possible location for a pore would be 22	
the 6-fold axis at the centre of each capsid protein (CA) hexamer but this is not evident from existing 23	
hexamer structures as it is obscured by the N-terminal β-hairpin.  By comparing all the available CA 24	
crystal structures with resolved β-hairpins5-11, including monomeric crystal forms, we observed that the 25	
β-hairpin can adopt alternate conformations that differ by up to 15 Å (as measured by the displacement 26	
of Q7) (Fig. 1a).  When reconstructed in the context of a hexamer, several of these β-hairpin 27	
conformations result in a pore about the six-fold axis (Fig. 1b).  The different β-hairpin conformations 28	
are the result of a pivoting movement of up to 37.5° about the N-terminal proline, an essential capsid 29	
residue that forms a salt-bridge with D5112 (Fig. 1a, Supplementary Video 1).  In structures where the 30	
pore would be open, D51 also participates in a second salt-bridge interaction with H12.  Conversely, in 31	
structures where the pore would be closed, including all previously solved disulfide-stabilised 32	
hexamers (CAHexamer), a water molecule has displaced the H12 side-chain and coordinates a tetrahedral 33	
hydrogen-bond network between H12, T48, Q50 and D51.  We hypothesized that the protonation state 34	
of H12 may be crucial in determining which arrangement is favored and therefore that the 35	
conformation of the β-hairpin in published structures will have been influenced by the pH at which 36	
they were solved. Remarkably, when the relative displacement of the β-hairpin (Q7 Cα) is plotted 37	
against crystallization pH the structures resolve into two groups; at pH < 7 an open pore β-hairpin 38	
conformation is observed whereas at pH > 7 a closed pore conformation is favored (Fig. 1c, Extended 39	
Data Table 1). The same correlation is observed when the distance between D51 and H12 is plotted 40	
against pH, confirming the importance of H12 in determining β-hairpin conformation. Structures 41	
solved at pH 7 display the greatest β-hairpin variability, consistent with maximum pore flexibility 42	
occurring under physiological conditions.  The likely reason why a pore has not been detected in 43	
published CAHexamer structures is because they were solved at a basic pH where H12 is deprotonated 44	
and a closed pore is favored.  To test this hypothesis and demonstrate that the pore can open in the 45	
context of an assembled hexamer, we sought to crystallise CAHexamer under acidic conditions.  We 46	
obtained a previously unreported crystal form at pH 5.5, the structure of which contains a β-hairpin in 47	
the open conformation and an exposed pore (Fig. 1b). 48	
 49	
Using all available CA structures to define a range of movement for the β-hairpin, we observed that the 50	
pivoting about P1 results in an iris-like motion, which creates an aperture on the outer surface of the 51	
capsid (Fig. 2a).  In the open state, a chamber 25 Å deep and 3240 Å3 in volume is revealed, which 52	
culminates in a ring of six arginine side-chains from residue 18 (Fig. 2b, Supplementary Video 2). This 53	
cluster of basic residues in close proximity results in highly electropositive foci at the centre of each 54	
hexamer. The R18 residues adopt multiple conformations (Extended Data Fig. 1a) to give a maximum 55	
pore diameter of 8 Å, sufficient to allow transit of a dNTP molecule. We therefore reasoned that this 56	
feature might provide an efficient means to recruit dNTP’s into the capsid interior (Fig. 2a) whilst 57	
excluding larger molecules.	 We therefore tested whether CAHexamer can interact with dNTP’s by 58	
fluorescence anisotropy and found that all four nucleotides bind with remarkably high affinity of 59	
between 6-40 nM (Fig. 2c). All biophysical measurements were undertaken in an ‘intracellular buffer’ 60	
(see Methods) that is designed to match salt concentrations in the cell.  We also observed that 61	
physiological concentrations of inorganic phosphate had little effect on dNTP binding and that the pore 62	
could not distinguish between dNTP’s and rNTP’s (Extended Data Fig. 2) consistent with the 63	
observation that rNMP’s are often incorporated into newly-synthesised viral DNA13.  Analyzing the 64	
kinetics of interaction by stopped-flow revealed that binding is driven by an extremely rapid on-rate of 65	
> 2x108 M-1 s-1, although this is likely an underestimate as the reaction becomes immeasurably fast at 66	
increasing reactant concentrations (Fig. 2d&e). Separate dissociation experiments in which fluorescent 67	
dCTP was displaced with excess unlabeled dCTP determined that the off-rate is also fast at >12 s-1 68	
(Fig. 2f), equivalent to a half life of 58 ms. Calculation of on-rates for all four nucleotides based on 69	
their steady-state affinities and off-rates confirms that HIV-1 hexamers achieve association rates 70	
between 108-109 M-1 s-1. These are unusually rapid association kinetics, typically found in enzymes that 71	
have achieved so-called kinetic perfection. Such ultra-rapid enzymes are rare because of the strong 72	
fitness advantage needed for their selection over merely very fast equivalents14. The rapid on-rate of 73	
dNTP recruitment that HIV achieves may be the result of an electrostatically assisted association 74	
binding mechanism, as has been described for barnase/barstar15. Importantly, the combination of fast 75	
on and off rates suggests that while the HIV-1 capsid may recruit dNTP’s extremely efficiently, these 76	
nucleotides quickly dissociate to become available as substrates for reverse transcription.   77	
 78	
To test our hypothesis that it is the ring of arginine residues that is responsible for nucleotide 79	
recruitment, we solved the structure of HIV-1 CAHexamer in complex with dATP and found that it binds 80	
as predicted in the center of the arginine ring via its phosphate groups (Fig. 2g). While there is electron 81	
density for the phosphates, the position of the base can only be modeled, likely because hexamer 82	
rotational symmetry allows the dATP base to occupy six equivalent positions, averaging its density 83	
over a large volume (Extended Data Fig. 1). Comparison with a structure solved under identical 84	
conditions, but in the absence of dATP, confirms that the observed density corresponds to the 85	
nucleotide.  To further investigate the importance of R18 in the recruitment of dNTP’s, we produced 86	
R18G and R18A CAHexamer mutants. Neither R18G nor R18A affected the overall structure of the 87	
protein and neither displayed measurable nucleotide binding (Fig. 3a&b). To determine whether 88	
formation of the arginines into a ring is required, we performed binding experiments on wild-type 89	
protein in the presence of DTT, which reduces the disulphide bonds that stabilise the hexameric 90	
construct, resulting in monomeric CA.  No binding was observed to monomeric CA demonstrating that 91	
once the pore is disassembled, the capsid can no longer recruit dNTP’s (Fig. 3b). 92	
 93	
The concentration of positive charge provided by the R18 ring is an unusual feature and might be 94	
expected to exert a destabilizing influence on the capsid lattice.  Conversely, it has been calculated that 95	
arginine pairs can stabilize protein interfaces16, while arginine clusters have been postulated to have a 96	
stabilizing effect17. We performed differential scanning fluorimetry (DSF) to compare the relative 97	
stability of CAHexamer with and without the electropositive pore. We observed a remarkable stability of 98	
the R18G hexamer relative to wild-type complex, corresponding to a surprisingly large increase in Tm 99	
of 4 °C (Fig. 3c, Extended Data Fig. 3).  A similar increase in stability was observed in wild-type 100	
hexamer in the presence of dNTP’s, while no stabilization was observed when dNTP’s were added to 101	
R18G hexamer (Fig. 3d). Taken together, these results suggest that the pore is indeed a destabilising 102	
feature that is tolerated by the capsid lattice in order to facilitate nucleotide binding.  An alignment of 103	
capsid sequences predicts an electropositive pore to be conserved across retrovirus genera, with the 104	
exception of the gammaretroviruses (Extended Data Fig. 4).  While there appears to be no R18-105	
equivalent in gammaretroviruses, analysis of the published MLV capsid structure reveals a large 106	
channel running down the six-fold axis with an inward facing Arg residue at position 3 (Mortuza et al. 107	
2008).   This residue may have a role in attracting dNTP’s, but it is unlikely that the MLV capsid has 108	
the same size-selectivity as the HIV capsid as the pore is much wider. 109	
 110	
The observation that HIV-1 has evolved the fastest possible rate constant for nucleotide recruitment 111	
suggests that dNTP import may be a limiting factor in reverse transcription and infectivity. To 112	
determine how the efficiency of nucleotide recruitment impacts on these measures of viral fitness, we 113	
constructed a matched set of chimeric WT:R18G CAHexamer and viruses (see Extended Data Fig. 5 for 114	
chimera controls).  R18G was chosen as its capsid morphology has previously been demonstrated to be 115	
indistinguishable from WT19. Furthermore, R18G was able to saturate the activity of capsid-binding 116	
restriction factor TRIM5α, confirming that assembled capsids enter the cytoplasm20 (Extended Data 117	
Fig. 6). We tested our chimeric hexamers for dNTP binding and found that an incorporation ratio of 5:1 118	
(5 arginines to 1 glycine) had a minimal impact on affinity (Fig. 3e). However, as the proportion of 119	
glycine residues was increased, there was a dose-dependent decrease in dNTP binding. Testing HIV-1 120	
GFP VSV-G pseudotyped chimeric viruses for infectivity revealed a similar pattern of R18 121	
dependence, in which there was little change in infectivity at a ratio of 5:1 but a dominant negative 122	
effect at higher G18 ratios (Fig. 3f). Assuming a binomial distribution of arginines and glycines in viral 123	
hexamers, the data fit a model in which removal of two or more arginines from the pore is detrimental 124	
to the virus (Extended Data Fig. 7), which is consistent with the observation that removal of one 125	
arginine has little impact on dNTP affinity.  Importantly, there is close correlation between chimera 126	
infectivity and nucleotide affinity, consistent with the recruitment of dNTP’s impacting directly on 127	
viral infection (Fig. 3g).  Such a mechanism would be expected to influence infection at the level of 128	
reverse transcription and indeed a similarly close correlation is observed between chimera affinity and 129	
the production of early reverse transcripts (Fig 3h). 130	
 131	
We propose that reverse transcription takes place within the protected environment of the capsid by 132	
recruiting nucleotides through a strongly electropositive pore at the center of each capsid hexamer.  In 133	
order to explore this further we performed endogenous reverse transcription (ERT) assays in which 134	
HIV-1 capsid cores were purified from virions21 and their reverse transcriptase activity quantified in 135	
vitro (Extended Data Fig. 8).  Efficient strong-stop reverse transcription (the first DNA synthesis step) 136	
was observed upon incubation of cores with dNTP’s.  Moreover, addition of DNase I, RNase A or the 137	
promiscuous nuclease Benzonase failed to prevent encapsidated reverse transcription (Fig. 4a, 138	
Extended Data Fig. 8e). This demonstrates that dNTP’s can access the interior of the capsid but larger 139	
nucleases cannot, supporting the notion of a size selective pore. Processivity beyond strong-stop was 140	
observed but at lower efficiency, in agreement with published data22.  141	
 142	
If the R18 pore is responsible for dNTP import, it is conceivable that capsid mutations that affect the 143	
movement of the β-hairpin may also affect the efficiency of reverse transcription.  Of the residues 144	
primarily responsible for the hairpin movement (Fig 1a), P1 and D51 are invariant, with mutations at 145	
these positions resulting in non-infectious particles due to defective capsid assembly12. His12 is also 146	
highly conserved, however, in ~2% of sequences it has been replaced by a tyrosine.  As tyrosine is not 147	
titratable over physiological pH’s, we hypothesised that the H12Y mutation would result in the β-148	
hairpin favouring one conformation.  Solving the crystal structure of this mutant revealed that under the 149	
high-pH condition, Y12 displaces the bound water molecule and makes a hydrogen-bond contact with 150	
Asp51 (Fig. 4b).  Despite contacting D51 directly, the larger sidechain of Y12 relative to H12 causes 151	
the β-hairpin to favour the closed conformation (Fig. 4c).  Importantly H12Y does not completely shut 152	
the pore because residues 4-9 do not occupy a single defined state (Extended Data Fig. 9).  The β-153	
hairpin therefore retains a degree of flexibility despite rigidification about the P1-D51 ‘hinge’.  154	
Nevertheless we predicted that favouring the closed conformation should result in H12Y having 155	
reduced RT kinetics while retaining some infectivity and this is what we observe (Fig. 4d). 156	
 157	
To provide further evidence that nucleotides are being recruited through the R18 pore to allow ERT, 158	
we sought a small molecule inhibitor that would block the pore. Small polyanionic compounds have 159	
been used previously to block analogous arginine-rich pores23. We found that the hexacarboxybenzene 160	
series (which are polyanionic at physiological pH) bound to CAHexamer and competed for nucleotide 161	
binding as measured by fluorescence anisotropy and DSF, respectively (Fig. 4e&f, Extended Data Fig. 162	
3). Activity broadly increased with the number of negative charges present within the compound, with 163	
hexa- or pentacarboxybenzene being the most effective. DSF indicated that the compounds did not 164	
bind in the absence of R18 or when hexamers were reduced by DTT, and the crystal structure of the 165	
hexacarboxybenzene-bound CAHexamer confirmed that the compound was co-ordinated by R18 within 166	
the central pore (Fig. 4f&g).  At sufficiently high concentration, tetra-, penta- and hexacarboxybenzene 167	
fully inhibit reverse transcriptase, presumably by competing with dNTP’s (Extended Data Fig. 8f).  168	
However, in ERT assays, when reverse transcriptase is enclosed within an intact viral capsid, 169	
tetracarboxybenzene has no effect on reverse transcription, with only a small effect observed for 170	
pentacarboxybenzene (Fig. 4h).  In contrast, hexacarboxybenzene inhibited ERT almost completely. 171	
The failure of tetracarboxybenzene to inhibit ERT demonstrates that a compound sufficiently small to 172	
pass through the channel is still efficiently excluded from the capsid interior if it cannot bind the pore. 173	
This result emphasises the chemical selectivity of the pore and its role in dNTP import during reverse 174	
transcription. 175	
 176	
As a semi-permeable reaction chamber, the HIV-1 capsid is reminiscent of bacterial 177	
microcompartments – primitive ‘organelles’ that utilize a protein coat to isolate toxic reaction 178	
intermediates from the cytoplasm24.  Microcompartments import substrates through a size-selective 179	
pore to be consumed by enzymes located inside a chamber25. Similarly, dNTP’s translocated inside the 180	
HIV capsid will be hydrolysed by encapsidated reverse transcriptase. Coupling import with hydrolysis 181	
may create a local chemical gradient, promoting interior movement despite the release of captured 182	
dNTP’s on either side of the pore. Appositely, a subset of microcompartments, carboxysomes, contain 183	
positively charged amino acids that are thought to selectively transport bicarbonate and ribulose-1,5-184	
bisphosphate over uncharged CO2 and O226. Some microcompartment structures have gated channels 185	
located at the six-fold axes in their protein lattice, to control substrate entry and product release. The 186	
fact that a similar ‘gate’ potentially exists in the HIV-1 capsid, provided by the ‘molecular iris’ of the 187	
β-hairpin, suggests that the virus could use this as a mechanism to regulate reverse transcription.  In 188	
addition, the regulation of capsid stability through dNTP recruitment, and possibly DNA synthesis, 189	
provides a model whereby HIV-1 may co-regulate DNA synthesis and uncoating to facilitate 190	
cytoplasmic DNA synthesis that remains invisible to cytoplasmic DNA sensing. Finally, the high 191	
degree of conservation of R18 coupled with the fact that the pore can be obstructed chemically 192	
identifies the pore as a novel target for drug development. 193	
 194	
  195	
Figures 196	
 197	
Figure 1: HIV-1 capsid hexamers have a pore at the center of their 6-fold symmetry axis. a, 198	
Superposition of N-terminal domains from solved capsid structures (PDB IDs: 1AK4, 2GON, 2X83, 199	
3H4E, 3NTE, 3P05, 4B4N and previously unpublished entries). A detailed view of the boxed region 200	
shows that the β-hairpin toggles between closed (green) and open (pink) states as a result of the 201	
hydrogen-bond network about P1, H12, and D51.  b, β-hairpin (coloured) conformations dictate the 202	
presence of a pore at the 6-fold axis. Hexamers of CA N-terminal domain (CANTD) structures have 203	
been assembled using symmetry operators from CAHexamer structures. c, Analysis of the salt-bridge 204	
between H12 and D51 and the movement of the β-hairpin as a function of crystallization pH. Acidic 205	
crystallization conditions promote an open β-hairpin conformation whilst basic conditions favor the 206	
closed state. 207	
 208	
  209	
 210	
Figure 2: The HIV-1 capsid pore is strongly electropositive and recruits dNTP’s with rapid 211	
association and dissociation kinetics. a, Model of an HIV-1 virion with hexamers in an open 212	
conformation reveals that the capsid is porous. Mapping the surface electrostatic potential shows that 213	
the pores are highly electropositive. b, Cross sections through the closed (β-hairpin green) and open (β-214	
hairpin pink) CAHexamer showing a central chamber that is accessible in the open state. R18 (cyan) 215	
creates a bottleneck at the base of the chamber underneath the β-hairpin. c, Fluorescence anisotropy 216	
measurements of dNTP’s binding to CAHexamer. d, Example of pre-steady state association kinetics of 217	
dCTP with CAHexamer. e, Apparent rate constant (kapp) at increasing CAHexamer concentrations. f, 218	
Dissociation of unlabeled dCTP:CAHexamer by excess fluorescent-dCTP. g, R18 co-ordinates the 219	
phosphates in a dATP-bound CAHexamer structure. 220	
 221	
  222	
 223	
Figure 3: Conserved capsid residue R18 is crucial for nucleotide recruitment, reverse 224	
transcription and infectivity. a, Superposed single monomers of R18G (light-pink) and wild-type 225	
(light-green) CAHexamer. b, Binding of capsid variants to dCTP as measured by fluorescence anisotropy. 226	
c, DSF stability measurements expressed as Tm for WT and R18G ± DTT. d, DSF measurements of the 227	
effect of dNTP’s on the stability of WT and R18G expressed as ΔTm relative to unbound. e, 228	
Fluorescence anisotropy titrations of dTTP-binding by chimeric CAHexamers with different R:G ratios at 229	
position 18. f, Comparison of infectivity and reverse transcription of chimeric viruses. g,h, Correlation 230	
between HIV-1 capsid dTTP affinity, viral infectivity g and reverse transcription h. 231	
 232	
  233	
 234	
Figure 4: HIV-1 reverse transcription is inhibited by blockade of the capsid pore a, In vitro 235	
endogenous reverse transcription measuring strong-stop transcripts. b, Residues surrounding Y12 in 236	
the H12Y hexamer structure.  c, Cartoon and surface representations of the β-hairpin in the H12Y 237	
hexamer. d, WT and H12Y reverse transcription kinetics. e, Competition binding of carboxybenzene 238	
compounds to CAHexamer. f, Change in wild type and R18G CAHexamer Tm as measured by DSF in the 239	
presence of carboxybenzene compounds. g, CAHexamer crystal structure in complex with 240	
hexacarboxybenzene, which is co-ordinated by R18. h, Effect of carboxybenzene compounds on 241	
endogenous reverse transcription. 242	
 243	
  244	
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 307	
Extended Data Figure 1: dATP binds to the R18 pore at the centre of the capsid hexamer.  2Fo-308	
Fc density (grey mesh) contoured at 1.0σ about R18 for the unbound (a) and dATP-bound (b) 309	
CAHexamer structures.  Fo-Fc omit density (green mesh) contoured at 3.0σ is shown for the dATP-bound 310	
structure.  c, dATP lies on the crystallographic 6-fold axis and significant rotationally-averaged density 311	
is observed only for the triphosphate group. 312	
  313	
 314	
Extended Data Figure 2: Controls for dNTP-binding experiment.  a, Titration of CAHexamer into 315	
2nM fluorescein-labelled dTTP in the presence of 1mM (physiological) or 5mM inorganic phosphate.  316	
Under the 1 mM conditions, there is no significant effect on hexamer binding to dTTP.  At 5 mM 317	
apparent affinity is decreased to 851 nM, demonstrating that inorganic phosphate can compete for the 318	
pore. However, given that the intracellular [dNTP] is approximately 100 µM, under intracellular 319	
conditions dNTP binding would dominate.  b, Titration of CAHexamer into BODIPY-labelled rGTP-γ-S 320	
and fluorescein-labelled dTTP.  Each binds with the same affinity suggesting that the R18 pore is 321	
unable to discriminate between ribose and deoxyribose nucleoside triphosphates.  The difference in the 322	
magnitude of the fluorescence anisotropy signals is due to differences in fluorophore excited state 323	
lifetimes.  KD values are indicated by a dotted line.  324	
  325	
 326	
Extended Data Figure 3: DSF melt curves. The left-hand panels report the ratio of tryptophan 327	
fluorescence emission at 350nm and 330nm as a function of temperature.  The right-hand panels report 328	
the first derivative of the same data, the peak of which is used to determine the Tm value. a, b, Effect of 329	
dATP and DTT on WT CAHexamer. c, d, Effect of dATP and DTT on R18G CAHexamer.  e, f, Effect of 330	
each dNTP on WT CAHexamer. g, h, Comparison of the effects of carboxybenzene compounds on WT 331	
CAHexamer. i, j, Comparison of the effects of hexacarboxybenzene on WT and R18G CAHexamer. 332	
  333	
 334	
Extended Data Figure 4:  Alignment of selected retrovirus capsid sequences bordering the 335	
electropositive pore.  The position equivalent to R18 in HIV is marked with an arrow. 336	
  337	
 338	
Extended Data Figure 5: Confirmation of CAHexamer Chimera Assemblies.  a, Non-reducing SDS-339	
PAGE of CAHexamer WT:R18G chimera samples demonstrates that the recombinant proteins had 340	
reassembled into hexamers.  Molecular weight standards (kDa) are presented in the first lane. b, 341	
Comparison of 1:5 homohexamer mix and the equivalent chimera.  The 1:5 WT:R18G mix experiences 342	
a six-fold loss of apparent Kd, as expected for a 6-fold dilution of WT with a non-binding mutant. In 343	
contrast, the 1:5 chimera chimera has a 58-fold decrease in Kd, demonstrating that chimeric hexamers 344	
had indeed formed. 345	
  346	
 347	
Extended Data Figure 6: R18G is capable of abrogating TRIM5α-mediated restriction. Rhesus 348	
TRIM5α provides a potent block to infection of HIV in FRhK-4 cells.  Titration of a non-GFP-349	
expressing virus can compete for TRIM5α-binding and relieve the restriction of a GFP-expressing 350	
virus only if it delivers an assembled capsid into the cytoplasm.  R18G abrogates restriction but 351	
W184A/M185A, which is incapable of forming assembled capsids due to loss of the CTD-CTD 352	
dimerization interface, does not. 353	
  354	
 355	
 356	
Extended Data Figure 7: Modelling the effect of progressive removal of arginines from the pore. 357	
a, Binomial distribution model for the relative proportion of capsid hexamers carrying a discrete 358	
number of glycines at position 18 at defined bulk ratios of WT:R18G. b, Six models (dotted lines) 359	
predicting the effect of replacing arginine 18 with glycines.  Each model assumes a different number of 360	
glycines is required to render the pore defective.  The data from WT:R18G chimeric virus 361	
measurements (solid line) is consistent with a model in which four or more arginines (i.e. 2 or fewer 362	
glycines, green) are required to maintain a functional pore. 363	
 364	
  365	
 366	
Extended Data Figure 8: ERT assay. a, HIV-1 cores were prepared by ultracentrifugation through a 367	
Triton X-100 layer over a sucrose gradient. Resulting fractions were subjected to ELISA for p24 and 368	
fractions 3 – 7 were pooled for further experiments. b, Endogenous RT activity for strong stop in the 369	
presence of DNase I using HIV-1 fractions that were prepared with or without the Triton X-100 spin-370	
through layer. Input levels of p24 were normalized between reactions. c, dNTP’s were added to HIV-1 371	
cores prepared by Triton X-100 spin-through in the presence of DNase I. Reactions were stopped at the 372	
indicated time point by shifting to -80˚ C and levels of strong stop were quantified. d, Levels of strong-373	
stop (RU5), first-strand transfer (1ST) and second-strand transfer (2ST) DNA after overnight 374	
incubation of HIV-1 cores with or without dNTP’s in the presence of DNase I. e, Levels of naked HIV-375	
1 DNA genomes untreated or incubated overnight with DNase I or Benzonase. f, Effect of 376	
carboxybenzene compounds on recombinant reverse transcriptase activity. 377	
  378	
 379	
Extended Data Figure 9: Comparison of WT and H12Y crystal structures. The H12Y monomer 380	
(in the context of the hexamer, purple) superposes on the WT (green) with RMSD = 0.2471 Å.  381	
Residues 4-9 of the H12Y structure have been modeled in two alternate conformations owing to 382	
flexibility towards the tip of the hairpin. 383	
  384	
Extended Data Table 1: Details of structures used for β-hairpin analysis 385	
 386	
  387	 Molecule	 Chain	 Resolution	 Crystallization	pH	 Q7	Displacement		 H12-D51	distance	5HGL	 A	 3.1	 5.5	 3	 2.9	5HGL	 B	 3.1	 5.5	 2.5	 3.1	5HGK	 A	 1.76	 6.3	 0	 2.7	5HGK	 B	 1.76	 6.3	 2.9	 2.7	3NTE	 A	 1.95	 6.5	 2	 2.9	3NTE	 B	 1.95	 6.5	 3.8	 2.8	2X83	 A	 1.7	 	7	 7.8	 3.7	1AK4	 C	 2.36	 7	 10	 4.8	2X83	 B	 1.7	 7	 9.2	 4.5	4B4N	 A	 1.81	 7	 13.1	 4.9	3H4E	 A	 2.7	 7.5	 10.4	 4.6	2GON	 C	 1.9	 8	 11.9	 4.8	3P05	 B	 2.5	 8.5	 14.8	 4.6	3P05	 C	 2.5	 8.5	 10.7	 4.6	
Extended Data Table 2: Crystallographic data collection and refinement statistics 388	
  389	
	 CANTD	(OPEN)	 CAHexamer	(OPEN)	 CAHexamer	+	dATP	 CAHexamer	(APO,	CLOSED)	 CAHexamer	(R18G)	 CAHexamer		+	Hexacarboxy-benzene	 CAHexamer	(H12Y)	
Data	
collection	
	 	 	 	 	 	 	Space	group	 P21	 C2221	 P6	 P6	 P6	 P6	 P6	Cell	dimensions  	 	 	 	 	 	 	 					a,	b,	c	(Å)	
 
43.72,	23.85,	129.55	 89.69,	159.27,	249.40	 90.81,	90.81,	56.68	 90.73,	90,73,	56.75	 90.81,	90.81,	56.88	 90.76,	90.76,	56.76	 90.60,	90.60,	56.93	
    α, β, γ 	(°)			 90,	96.31,	90	 90,	90,	90	 90,	90,	120	 90,	90,	120	 90,	90,	120	 90,	90,	120	 90,	90,	120	Resolution	(Å)		 39.87-1.76	(1.86-1.76)	 19.99-3.10	(3.27-3.10)	 45.98-2.03	(2.08-2.03)	 26.69-1.90	(1.94-1.90)	 46.09-2.00	(2.05-2.00)	 45.38-1.95	(2.00-1.95)	 56.93-1.70	(1.73-1.70)	
Rmerge		 0.065	(0.227)	 0.094	(0.552)	 0.112	(0.551)	 0.121	(0.748)	 0.166	(0.831)	 0.105	(0.862)	 0.095	(0.813)	
I	/	σI	 13.3	(5.0)	 7.1	(1.9)	 8.2	(1.9)	 8.3	(2.1)	 6.5	(1.9)	 11.7	(2.1)	 9.0	(2.4)	Completeness	(%)	 91.9	(80.6)	 97.4	(92.0)	 94.9	(69.1)	 99.8	(100.0)	 100.0	(100.0)	 97.9	(99.5)	 95.1	(94.7)	Redundancy	 4.6	(4.6)	 2.4	(2.4)	 2.9	(2.4)	 5.1	(4.8)	 6.0	(5.9)	 6.8	(6.5)	 4.8	(4.9)	
	 	 	 	 	 	 	 	
Refinement	 	 	 	 	 	 	 	Resolution	(Å)		 39.87-1.76	(1.81-1.76)	 19.99-3.10	(3.18-3.10)	 45.98-2.04	(2.10-2.04)	 26.69-1.90	(1.95-1.90)	 39.32-2.00	(2.05-2.00)	 45.38-1.95	(2.00-1.95)	 56.93-1.70	(1.74-1.70)	No.	reflections		 23837	(1552)	 30312	(2044)	 15488	(1084)	 19999	(1468)	 17285	(1246)	 18188	(1347)	 26370	(1949)	
Rwork	/	Rfree		 0.190/0.224	(0.233/	0.286)	 0.250/0.281	(0.368/	0.399)	 0.236/0.263	(0.316/	0.384)	 0.200/0.225	(0.266/	0.342)	 0.205/0.221	(0.216/	0.255)	 0.194/0.221	(0.266/	0.299)	 0.197/0.232	(0.265/	0.285)	No.	atoms	 	 	 	 	 	 	 					Protein	 2284	 9358	 1558	 1623	 1605	 1612	 1688					Ligand/ion	 1	 193	 30	 -	 -	 24	 -					Water	 338	 -	 82	 124	 105	 119	 123	
B-factors	 	 	 	 	 	 	 					Protein	 27.928	 54.173	 26.577	 30.265	 27.732	 30.878	 27.523					Ligand/ion	 38.516	 83.117	 109.040	 -	 -	 95.409	 -					Water	 24.730	 -	 30.031	 35.719	 28.567	 34.088	 33.604	R.m.s.	deviations	 	 	 	 	 	 	 					Bond	lengths	(Å)	 0.007	 0.008	 0.007	 0.007	 0.007	 0.008	 0.006					Bond	angles	(°)	 1.222	 1.156	 0.991	 0.998	 1.046	 1.281	 1.009	
Methods 390	
 391	
Protein production and purification 392	
The CA N-terminal domain and the disulfide-stabilised CAHexamer were expressed and purified as 393	
previously described8,27.  The R18G mutation was introduced by QuikChange site-directed 394	
mutagenesis.  Chimeric CAHexamers were produced by mixing the desired ratio of pre-assembled WT and 395	
R18G CAHexamer (16 mg/ml) followed by a four-step dialysis: i) Disassembly in TRIS (pH 8.0, 50mM), 396	
NaCl (40mM), β-mercaptoethanol (20mM); ii) Reassembly in TRIS (pH 8.0, 50mM), NaCl (1 M), β-397	
mercaptoethanol (20mM); iii) Oxidation in TRIS (pH 8.0, 50mM), NaCl (1 M); Redispersion in TRIS 398	
(pH 8.0, 20mM), NaCl (40mM).  In the context of the chimera experiments, WT and R18G were also 399	
subjected to this process so that samples were matched with the other ratios.  Reassembled hexamers 400	
were observed by non-reducing SDS-PAGE. Chimeric hexamers were compared with mixes of 401	
homohexamers by fluorescence anisotropy (see below and Extended Data Fig. 5) in order to 402	
demonstrate that chimeras had indeed formed. 403	
 404	
Crystallisation, structure solution and analysis 405	
All crystals were grown at 17 °C by sitting-drop vapour diffusion in which 100 nL protein was mixed 406	
with 100 nL precipitant and suspended above 80 uL precipitant.  The CA N-terminal domain 407	
(15mg/ml) ‘open’ conformation was crystallised from PEG3350 (20%), Ammonium chloride (0.2M, 408	
pH 6.3).  Crystals were cryoprotected in precipitant supplemented with 25% glycerol.  The CAHexamer 409	
(15 mg/ml) ‘open conformation’ was crystallised from PEG4000 (12%), NaCl (0.1M), MgCl2 (0.1M), 410	
sodium citrate (0.1M, pH 5.5).  Crystals were cryoprotected in precipitant supplemented with 20% 411	
MPD.  The remaining CAHexamer structures (apo, dATP-bound, R18G and hexacarboxybenzene-bound) 412	
were all obtained from 10-12mg/ml protein mixed with PEG550MME (13-14%), KSCN (0.15M), 413	
TRIS (0.1M, pH 8.5) and cryoprotected with precipitant supplemented with 20% MPD.  For the dATP-414	
bound structure, the protein was supplemented with 10 mM dATP immediately prior to crystallisation; 415	
while for the hexacarboxybenzene structure, the protein was likewise supplemented with 1 mM 416	
hexacarboxybenzene (TRIS-buffered to pH 8.0).  All crystals were flash-cooled in liquid nitrogen and 417	
data collected either in-house using Cu Kα X-rays produced by a Rigaku FR-E rotating anode generator 418	
with diffraction recorded on a mar345 image plate detector (marXperts), or at beamline I02 at Diamond 419	
Light Source.  The datasets were processed using the CCP4 program suite28.  Data were indexed and 420	
integrated with IMOSFLM29 and scaled and merged with either POINTLESS and SCALA30 or 421	
AIMLESS31.  Structures were solved by molecular replacement using PHASER32 and refined using 422	
REFMAC533.  Between rounds of refinement, the model was manually checked and corrected against 423	
the corresponding electron-density maps in COOT34.  Solvent molecules and bound ligands were added 424	
as the refinement progressed either manually or automatically within COOT and were routinely 425	
checked for correct stereo-chemistry, for sufficient supporting density above a 2Fo-Fc threshold of 426	
1.0σ and for a reasonable thermal factor. The quality of the model was regularly checked for steric 427	
clashes, incorrect stereochemistry and rotamer outliers using MOLPROBITY35.  Final figures were 428	
rendered in The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.  Surface 429	
electrostatics were calculated using the APBS PyMOL plugin36 and cavity volume measurements with 430	
3V37.  Data collection and refinement statistics are presented in Extended Data Table 2. The ‘fullerene 431	
cone’ model of an HIV-1 virion is based on 3J3Q38 but using the inter-hexamer packing from 4XFY39 432	
and an open β-hairpin conformation. 433	
 434	
Fluorescence Anisotropy 435	
Fluorescence anisotropy measurements were performed at 22 °C on a Cary Eclipse Fluorescence 436	
Spectrophotometer (Agilent).  Fluorescein-labelled dNTP’s were obtained from Perkin Elmer and used 437	
for saturation binding experiments at a concentration of 2nM prepared in ‘Intracellular Buffer’: 438	
potassium gluconate (110mM), KCl (25mM), NaCl (5mM), MgCl2 (2mM), HEPES (10mM), final pH 439	
7.2.  CAHexamer disassembly was achieved by the addition of DTT (4mM), and was performed routinely 440	
at the conclusion of each saturation binding experiment to confirm the absence of non-specific binding.  441	
It was found that the triphosphate was not stable over the timescale of the competition binding 442	
experiments; so fluorescein-labelled dNTP’s were substituted for a non-hydrolysable BODIPY-labelled 443	
GTP-γ-S (ThermoFisher Scientific).  Saturation binding experiments determined that this non-444	
hydrolysable analogue bound with unchanged affinity to the CAHexamer (Kd = 14nM).  200 mM stock 445	
solutions of hexacarboxybenzene (Sigma), pentacarboxybenzene (MP Biomedicals), 1,2,4,5-446	
tetracarboxybezene (Sigma), and 1,3,5-tricarboxybenzene (Fluka) were prepared in 50mM TRIS and 447	
adjusted to pH 8.0. For competition binding experiments, the competitor was titrated into a mix of 448	
CAHexamer (28nM) and BODIPY-GTP-γ-S (2nM).  All fluorescence anisotropy measurements are 449	
representative of at least two experiments.  Each point is measured in quadruplicate and plotted as 450	
mean ± standard deviation.  In many cases error bars lie within the datapoint.  Saturation binding and 451	
competition binding curves were fit using GraphPad Prism  (GraphPad Software, Inc.). 452	
 453	
Rapid reaction kinetics 454	
Experiments were carried out using a dual-channel fluorescence TgK single-mix SF-61SX2 stopped-455	
flow spectrometer. All samples were prepared in Intracellular Buffer. Mixing was performed 1:1, using 456	
an excitation wavelength of 488 nm and a 520 nm cutoff filter. Association experiments were carried 457	
out at 0.25 µM dCTP and a range of µM CAHexamer concentrations. Dissociation experiments were 458	
carried out using 20 µM unlabeled dCTP and a pre-formed fluorescein-labeled 1µM dCTP: CAHexamer 459	
complex. Relaxation rates were determined using a single exponential model: F = ΔF exp(-kobst) + Fe, 460	
where F is the observed fluorescence, ΔF is the fluorescence amplitude, kobs is the observed pseudo 461	
first-order rate constant, and Fe is the end-point fluorescence. The bimolecular association rate constant 462	
(kon) was determined by fitting the linear relationship between kobs and the increasing pseudo-first order 463	
concentrations of CAHexamer to: kobs = kon[CAHexamer] + kreverse. For stopped flow experiments, every 0.5 s 464	
measurement included >2000 datapoints, each of which was oversampled 99 times. At least three 465	
independent mixing experiments were averaged for each ligand concentration. 466	
 467	
Differential Scanning Fluorimetry 468	
DSF measurements were performed using a Prometheus NT.48 (NanoTemper Technologies) over a 469	
temperature range of 20-95 °C using a ramp rate of 2.5 °C/min.  CAHexamer samples were prepared at a 470	
final concentration of 1mg/ml in Intracellular Buffer (+/- DTT (4mM)).  dNTP’s or competitors were 471	
added at 200 µM.  DSF scans are single reads. Consistency between like points yields an uncertainty in 472	
Tm of no greater than 0.2 °C. 473	
 474	
Cells and Viruses 475	
Replication deficient VSV-G pseudotyped HIV GFP vectors were produced in HEK293T cells as 476	
described previously3.  Site-directed mutagenesis of CA was performed using the QuikChange method 477	
(Stratagene) against the Gag-Pol expression plasmid, pCRV-1.  Chimeric viruses were produced by 478	
mixing the appropriate ratio of WT or mutant pCRV-1 prior to transfection. Reverse transcriptase 479	
activity was quantified using a colorimetric ELISA assay (Roche) and was found not to vary 480	
significantly between viruses. Production of mature particles was confirmed by western blot for p24 481	
from pelleted virus, with no observable difference between chimeras. 482	
 483	
Infection Experiments 484	
Infections of HeLa cells were performed in the presence of 5 µg/ml polybrene. GFP expressing cells 485	
were enumerated on a BD LSRII Flow Cytometer (BD Biosciences) 2 days post-transfection after 486	
fixation of cells in 4% paraformaldehyde.  Chimera infectivity was determined by a 6-point titration of 487	
each chimera onto HeLa cells.  Values are the mean ± standard deviation calculated from all points for 488	
which the proportion of infected cells after 48 h was between 1% and 50%.   489	
 490	
TRIM5α Abrogation Assay 491	
‘Abrogating virus’ (VSV-G pseudotyped HIV Puromycin vectors) was produced as described above, 492	
with the exception that the gfp gene was replaced with the pac gene to ensure the virus did not confer 493	
fluorescence upon infection. Virus was concentrated by ultracentrifugation with an SW28 rotor at 494	
25,000 rpm for 2 h. The abrogating virus capsids were WT, R18G or W184A/M185A (a mutant with a 495	
known assembly defect that cannot compete for TRIM5α).  VSV-G pseudotyped HIV GFP vectors 496	
were titrated on FRhK-4 cells in the presence of 5 µg/ml polybrene to determine the volume of virus 497	
required to achieve 1% infection.  In a separate experiment, cells were then coinfected with that 498	
amount HIV-GFP vector and a titration of VSV-G pseudotyped HIV Puromycin vectors (the 499	
abrogating virus). GFP expressing cells were measured in duplicate and enumerated as above.  Results 500	
are representative of three experiments and are presented as mean ± standard deviation.  For many 501	
points the error bars lie within the datapoint. 502	
 503	
Quantitative PCR 504	
For analysis of reverse transcription products, viral supernatant was treated with 250 U/ml DNase 505	
(Millipore) for 1 h prior to infection. Cells were harvested 6h post infection.  DNA was extracted using 506	
DNeasy Blood and Tissue Kit (Qiagen). GFP copies were quantified using primers GFPF 507	
(CAACAGCCACAACGTCTATATCAT), GFPR (ATGTTGTGGCGGATCTTGAAG) and probe 508	
GFPP (FAM-CCGACAAGCAGAAGAACGGCATCAA-TAMRA) against a standard curve of CSGW 509	
on an ABI StepOnePlus Real Time PCR System (Life Technologies).  Chimera reverse transcription 510	
measurements are representative of 3 experiments with each point measured in triplicate.  Results are 511	
presented as mean ± standard deviation.  For H12Y, a timecourse was also performed, in which each 512	
time point was measured in triplicate and presented as above. 513	
 514	
Preparation of HIV-1 cores 515	
HIV-1 capsid cores were prepared using a protocol based on21 with modifications. 90ml HEK293T 516	
supernatant containing VSV-G pseudotyped HIV-1 GFP was pelleted over 20% sucrose dissolved in 517	
core prep buffer (CPB; 20 mM Tris pH 7.4, 20 mM NaCl, 1 mM MgCl2) in an SW28 rotor (Beckman) 518	
at 25,000 rpm at 4˚ C. Pellets were gently resuspended at 4˚ C in CPB for 1 h with occasional agitation. 519	
Resuspended pellets were treated with DNase I from bovine pancreas (Sigma Aldrich) for 1 h at 200 520	
µg/ml at room temperature to remove contaminating extra-viral DNA. Virus was subjected to spin-521	
through detergent stripping of the viral membrane as follows. A gradient at 80-30% sucrose was 522	
prepared in SW40Ti ultracentrifuge tubes and overlaid with 250 µl 1% Triton X-100 in 15% sucrose, 523	
followed by 250 µl 7.5% sucrose. All solutions were prepared in CPB. 750 µl DNase-treated, 524	
concentrated virus was layered on top of the gradient and subjected to 32,500 rpm at 4˚ C for 16 h. The 525	
preparation was fractionated and the location of cores was determined by ELISA for p24 (Perkin 526	
Elmer). Core-containing fractions were pooled and snap frozen before storage at -80˚ C. 527	
 528	
Endogenous reverse transcription assays 529	
Viral cores were diluted to 400 µg/ml p24 with 60% sucrose in CPB and pre-treated with nucleases for 530	
1h before addition of dNTPs. Final concentrations of dNTP’s were 100 µM each, DNase I and RNase 531	
A were at 100 µg/ml and Benzonase was at 250 U/ml. 20 µl reactions were incubated at room 532	
temperature for 16 h unless indicated otherwise and were stopped by shifting to -80˚ C. DNA was 533	
prepared using DNeasy Blood and Tissue kit (Qiagen) after addition of 200 µl PBS with of 50 µg/ml 534	
salmon sperm carrier DNA to each sample. Reverse transcript products were detected using TaqMan 535	
Fast Universal PCR Mix (ABI) and RU5 primers to detect strong stop DNA40 (RU5 fwd 536	
TCTGGCTAACTAGGGAACCCA, RU5 rev CTGACTAAAAGGGTCTGAGG and RU5 probe FAM-537	
TTAAGCCTCAATAAAGCTTGCCTTGAGTGC-TAMRA), GFP primers to detect first strand 538	
transfer products (described above) and primers for second strand transfer products40 (2ST fwd 539	
TTTTAGTCAGTGTGGAAAATCTGTAGC, 2ST rev TACTCACCAGTCGCCGCC and 2ST probe 540	
FAM-TCGACGCAGGACTCGGCTTGCT-TAMRA). Where used, carboxybenzene compounds were 541	
dissolved in CPB, pH adjusted with NaOH and added to reactions at a final concentration of 20mM. In 542	
order for dNTP concentration to be limiting, these reactions were performed in the presence of 1 µM 543	
each dNTP and reactions were stopped 5 h after their addition. ERT experiments were performed in 544	
experimental triplicate and are representative of several experimental replicates.  Data are represented 545	
as mean ± sem 546	 	547	
Supplementary Video 1: Structural morph between the closed and open states of CAHexamer. On 548	
the left the protein is represented in cartoon format, coloured according to secondary structure.  The 549	
sidechain of L6 is shown as sticks to emphasise that it is this residue that results in pore closure.  On 550	
the right P1, H12, T48, Q50, and D51 are represented as sticks to show that the movement of the β-551	
hairpin is driven by the formation of a salt-bridge between H12 and D51.  Distances shown are in 552	
Ångstroms. 553	
 554	
Supplementary Video 2: Pore opening exposes R18.  Surface representation of the morph depicted 555	
in Supplementary Video 1.  The β-hairpin and R18 are coloured yellow and blue, respectively. 556	 	557	
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